Dahan Michel - Insider Non-Derivative Transactions at Akebia Therapeutics, Inc. (AKBA) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on May 13, 2024, Dahan Michel's relationship to Akebia Therapeutics, Inc. (AKBA) is Officer (SVP, Chief Operating Officer), and currently has 672,092 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AKBA insiders.

Data Source: SEC.
Dahan Michel - Insider Non-Derivative Transactions of AKBA Common Stock
Dahan Michel - Insider Non-Derivative Transactions at AKBA
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
May 14, 2024 Sell -- (Common Stock) 34840 1.26 672092
Mar 1, 2024 Sell -- (Common Stock) 8661 1.58 706932
Feb 28, 2024 Sell -- (Common Stock) 10744 1.52 715593
Feb 1, 2024 Acquisition -- (Common Stock) 149300 0 726337
May 26, 2023 Sell -- (Common Stock) 95478 1.22 574037
May 25, 2023 Acquisition -- (Common Stock) 200000 0 669515
May 13, 2023 Acquisition -- (Common Stock) 200000 0 469515
Mar 2, 2023 Sell -- (Common Stock) 1878 0.88 269515
Mar 2, 2023 Sell -- (Common Stock) 10476 0.88 271393
Mar 2, 2023 Sell -- (Common Stock) 8058 0.88 281869
Feb 28, 2023 Sell -- (Common Stock) 10090 0.81 289927